Sopharma Trading AD (XBUL:SFT) EV-to-EBIT : 7.19 (As of Jul. 20, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sopharma Trading AD's Enterprise Value is лв497 Mil. Sopharma Trading AD's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was лв69 Mil. Therefore, Sopharma Trading AD's EV-to-EBIT for today is 7.19.

The historical rank and industry rank for Sopharma Trading AD's EV-to-EBIT or its related term are showing as below:

XBUL:SFT' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.53 Med: 22.38 Max: 41.69
Current: 7.19

During the past 13 years, the highest EV-to-EBIT of Sopharma Trading AD was 41.69. The lowest was 6.53. And the median was 22.38.

XBUL:SFT's EV-to-EBIT is ranked better than
73.96% of 96 companies
in the Medical Distribution industry
Industry Median: 12.47 vs XBUL:SFT: 7.19

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sopharma Trading AD's Enterprise Value for the quarter that ended in Mar. 2025 was лв490 Mil. Sopharma Trading AD's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was лв69 Mil. Sopharma Trading AD's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 14.10%.

Sopharma Trading AD EV-to-EBIT Historical Data

The historical data trend for Sopharma Trading AD's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD EV-to-EBIT Chart

Sopharma Trading AD Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

25.78

29.68

25.75

10.42

8.19

Sopharma Trading AD Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															10.40	8.57	9.65	8.19	7.09

Competitive Comparison of Sopharma Trading AD's EV-to-EBIT

For the Medical Distribution subindustry, Sopharma Trading AD's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma Trading AD's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Sopharma Trading AD EV-to-EBIT Calculation

Sopharma Trading AD's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	497.313	/	69.157
	=	7.19

Sopharma Trading AD's current Enterprise Value is лв497 Mil.
Sopharma Trading AD's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was лв69 Mil.

Sopharma Trading AD (XBUL:SFT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sopharma Trading AD's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 )	=	EBIT	/	Enterprise Value (Q: Mar. 2025 )
	=	69.157	/	490.4576
	=	14.10 %

Sopharma Trading AD's Enterprise Value for the quarter that ended in Mar. 2025 was лв490 Mil.
Sopharma Trading AD's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was лв69 Mil.

Sopharma Trading AD EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD Headlines

No Headlines